The North America 3D cell culture market is estimated to project a CAGR of 11.85% during the forecast period. It had the largest market share as a result of increasing demand for 3D cell culture, technological advancements, rising diseases along in infrastructural developments, etc. The North American 3D cell culture market is assessed on the basis of the United States and Canada. In the United States market, rising chronic diseases is driving the demand for 3D cell culture. Moreover, the active participation of the companies in the production and provision of 3D cell culture is driving the growth of the market.

 

NORTH AMERICA 3D CELL CULTURE MARKET FORECAST 2026

North America 3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free, 3D Bioreactors) by Application( Cancer, Tissue Engineering & Immunohistochemistry, Drug Development, Stem Cell Research, Other Applications) by End-users(Biotechnology and Pharmaceutical Organizations, Research Laboratories and Institutes, Hospitals and Diagnostic Centers, Other End Users) by Component(Media, Reagents and Consumables) & by Geography

Request free sample

The North America 3D cell culture market is estimated to project a CAGR of 11.85% during the forecast period. The region holds the largest market share, supported by growing demand for physiologically relevant in vitro models, rapid technological advancements, a rising burden of chronic and degenerative diseases, and well-developed research infrastructure.

The most significant recent driver is regulatory. On 10 April 2025, the FDA announced a plan to reduce, refine, or replace its animal testing requirement using approaches including AI-based computational toxicity models and cell line and organoid toxicity testing — collectively termed New Approach Methodologies (NAMs) — with implementation beginning immediately for investigational new drug applications. The NIH followed on 29 April 2025 by launching the Office of Research Innovation, Validation and Application (ORIVA) to advance human-centric organ-on-a-chip technologies. In March 2026, the FDA issued draft guidance to help developers validate NAMs — including organoids, spheroids, and organs-on-chips — for use in regulatory submissions, and on 20 April 2026 published a one-year progress report, “Reducing Animal Testing in Nonclinical Studies: Year One Progress and the Path Forward.” The roadmap targets making animal testing “the exception rather than the norm” in preclinical safety testing within three to five years.

The market is assessed on the basis of the United States and Canada. In the United States, rising chronic disease prevalence, dense concentration of pharmaceutical and biotech firms, and this regulatory shift are accelerating adoption of spheroid, organoid, and microphysiological systems. Federal investment is scaling accordingly — Johns Hopkins University, for example, received $15 million over five years to establish an organoid-focused technology development center. The Canadian market is estimated to grow at a significant rate, driven by established molecular R&D laboratories, provincial innovation funding, and active organoid research programs at universities across Ontario, Alberta, and Quebec.

Competitive activity has intensified. Key suppliers include Thermo Fisher Scientific, Corning, STEMCELL Technologies (Vancouver), Danaher’s Crown Bioscience, Emulate, and HUB Organoids. Corning continues to expand its 3D portfolio around Elplasia microcavity plates and Matrigel matrix for organoid culture, adding higher-density formats in 2026. In November 2025, InSphero acquired DOPPL SA along with Sun Bioscience’s Gri3D organoid platform, consolidating scalable spheroid and organoid technologies under one portfolio.

Nano3D Biosciences, Inc. (n3D), founded in 2008 in Houston, Texas, developed magnetic 3D bioprinting technology. It was acquired by Greiner Bio-One International on 8 May 2018 and its platform is now marketed through Greiner’s global bioscience channels for biomedical research, drug discovery, precision medicine, assay development, and oncology and toxicity screening.

To request a free sample copy of this report, please complete the form below:

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • SCAFFOLD FREE IS THE FASTEST GROWING 3D CELL CULTURE TECHNOLOGY
      • STEM CELL RESEARCH IS THE WIDELY USED APPLICATION
      • BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS ARE THE MAJOR END USER
      • REAGENTS AND CONSUMABLES ARE THE MAJOR USED COMPONENT
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING DEMAND FOR 3D CELL CULTURE PLATFORMS
      • TECHNOLOGICAL ADVANCEMENT
      • INCREASED FOCUS ON THE REGENERATIVE MEDICINE
      • RISING NORTH AMERICA R&D INVESTMENTS IN CELL BASED RESEARCH
    • MARKET RESTRAINTS
      • EXPENSES ASSOCIATED WITH THE IMPLEMENTATION OF 3D CELL CULTURE
      • LACK OF SKILLED PROFESSIONALS
      • LACK OF CONSISTENCY IN RESULTS
    • MARKET OPPORTUNITIES
      • USAGE OF THE 3D CULTURE IN DRUG SCREENING AND ORGAN TRANSPLANTATION
      • RISE IN THE PREVALENCE RATE OF CANCER
    • MARKET CHALLENGES
      • CHALLENGES ASSOCIATED WITH DEVELOPING OPTIMIZED 3D CELL CULTURE
      • LIMITED DATA AVAILABILITY DUE TO RESTRICTED RESEARCH ON CELL CULTURE
  1. MARKET BY TECHNOLOGY
    • SCAFFOLD BASED
      • HYDROGELS
      • POLYMERIC SCAFFOLDS
      • MICROPATTERNED SURFACE MICROPLATES
    • SCAFFOLD FREE
      • HANGING DROP MICROPLATES
      • SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
      • MICROFLUIDIC 3D CELL CULTURE
      • MAGNETIC LEVITATIONS & 3D BIOPRINTING
    • 3D BIOREACTORS
  2. MARKET BY APPLICATION
    • CANCER
    • TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY
    • DRUG DEVELOPMENT
    • STEM CELL RESEARCH
    • OTHER APPLICATION
  3. MARKET BY END-USER
    • BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS
    • RESEARCH LABORATORIES AND INSTITUTES
    • HOSPITALS AND DIAGNOSTIC CENTERS
    • OTHER END USERS
  4. MARKET BY COMPONENT
    • MEDIA
    • REAGENTS AND CONSUMABLES
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • POLITICAL & LEGAL, ECONOMIC, AND TECHNOLOGICAL ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • 3D BIOTEK LLC
    • BECTON DICKINSON AND COMPANY
    • CORNING INC.
    • EMULATE
    • GE HEALTHCARE
    • INSPHERO
    • LONZA GROUP AG
    • MERCK KGAA
    • NANO3D BIOSCIENCES, INC.
    • PROMOCELL GMBH
    • TECAN TRADING AG.
    • THERMO FISHER SCIENTIFIC INC.
    • VWR INTERNATIONAL, LLC

LIST OF TABLES

TABLE   1      NORTH AMERICA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)

TABLE   2      NORTH AMERICA 3D CELL CULTURE MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE   3      NORTH AMERICA SCAFFOLD BASED MARKET, 2019-2027 ($ MILLION)

TABLE   4      NORTH AMERICA SCAFFOLD BASED MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE   5      NORTH AMERICA HYDROGELS MARKET, 2019-2027 ($ MILLION)

TABLE   6      NORTH AMERICA POLYMERIC SCAFFOLDS MARKET, 2019-2027 ($ MILLION)

TABLE   7      NORTH AMERICA MICROPATTERNED SURFACE MICROPLATES MARKET, 2019-2027 ($ MILLION)

TABLE   8      NORTH AMERICA SCAFFOLD FREE MARKET, 2019-2027 ($ MILLION)

TABLE   9      NORTH AMERICA SCAFFOLD FREE MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE   10    NORTH AMERICA HANGING DROP MICROPLATES MARKET, 2019-2027 ($ MILLION)

TABLE   11    NORTH AMERICA SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING MARKET, 2019-2027 ($ MILLION)

TABLE   12    NORTH AMERICA MICROFLUIDIC 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)

TABLE   13    NORTH AMERICA MAGNETIC LEVITATIONS & 3D BIOPRINTING MARKET, 2019-2027 ($ MILLION)

TABLE   14    NORTH AMERICA 3D BIOREACTORS MARKET, 2019-2027 ($ MILLION)

TABLE   15    NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE   16    NORTH AMERICA CANCER MARKET, 2019-2027 ($ MILLION)

TABLE   17    NORTH AMERICA TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY MARKET, 2019-2027 ($ MILLION)

TABLE   18    NORTH AMERICA DRUG DEVELOPMENT MARKET, 2019-2027 ($ MILLION)

TABLE   19    NORTH AMERICA STEM CELL RESEARCH MARKET, 2019-2027 ($ MILLION)

TABLE   20    NORTH AMERICA OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)

TABLE   21    NORTH AMERICA 3D CELL CULTURE MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE   22    NORTH AMERICA BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS MARKET, 2019-2027 ($ MILLION)

TABLE   23    NORTH AMERICA RESEARCH LABORATORIES AND INSTITUTES MARKET, 2019-2027 ($ MILLION)

TABLE   24    NORTH  AMERICA HOSPITALS AND DIAGNOSTIC CENTERS MARKET, 2019-2027 ($ MILLION)

TABLE   25    NORTH AMERICA OTHER END USER MARKET, 2019-2027 ($ MILLION)

TABLE   26    NORTH AMERICA 3D CELL CULTURE MARKET, BY COMPONENT, 2019-2027 ($ MILLION)

TABLE   27    USAGE OF MEDIA IN DIFFERENT STAGES OF ORGANOIDS FORMATION

TABLE   28    NORTH AMERICA MEDIA MARKET, 2019-2027 ($ MILLION)

TABLE   29    NORTH AMERICA REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)

TABLE   30    NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE   1   NORTH AMERICA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)

FIGURE   2   NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BY TECHNOLOGY 2018 & 2027 (%)

FIGURE   3   NORTH AMERICA 3D CELL CULTURE MARKET, BY SCAFFOLD BASED, 2019-2027 ($ MILLION)

FIGURE   4   NORTH AMERICA 3D CELL CULTURE MARKET, BY HYDROGELS, 2019-2027 ($ MILLION)

FIGURE   5   NORTH AMERICA 3D CELL CULTURE MARKET, BY POLYMERIC SCAFFOLDS, 2019-2027 ($ MILLION)

FIGURE   6   NORTH AMERICA 3D CELL CULTURE MARKET, BY MICROPATTERNED SURFACE MICROPLATES, 2019-2027 ($ MILLION)

FIGURE   7   NORTH AMERICA 3D CELL CULTURE MARKET, BY SCAFFOLD FREE, 2019-2027 ($ MILLION)

FIGURE   8   NORTH AMERICA 3D CELL CULTURE MARKET, BY HANGING DROP MICROPLATES, 2019-2027 ($ MILLION)

FIGURE   9   NORTH AMERICA 3D CELL CULTURE MARKET, BY SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING, 2019-2027 ($ MILLION)

FIGURE   10 NORTH AMERICA 3D CELL CULTURE MARKET, BY MICROFLUIDIC 3D CELL CULTURE, 2019-2027 ($ MILLION)

FIGURE   11 NORTH AMERICA 3D CELL CULTURE MARKET, BY MAGNETIC LEVITATIONS & 3D BIOPRINTING, 2019-2027 ($ MILLION)

FIGURE   12 NORTH AMERICA 3D CELL CULTURE MARKET, BY 3D BIOREACTORS, 2019-2027 ($ MILLION)

FIGURE   13 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)

FIGURE   14 NORTH AMERICA 3D CELL CULTURE MARKET, BY CANCER, 2019-2027 ($ MILLION)

FIGURE   15 NORTH AMERICA 3D CELL CULTURE MARKET, BY TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY, 2019-2027 ($ MILLION)

FIGURE   16 NORTH AMERICA 3D CELL CULTURE MARKET, BY DRUG DEVELOPMENT, 2019-2027 ($ MILLION)

FIGURE   17 NORTH AMERICA 3D CELL CULTURE MARKET, BY STEM CELL RESEARCH, 2019-2027 ($ MILLION)

FIGURE   18 NORTH AMERICA 3D CELL CULTURE MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)

FIGURE   19 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BY END-USER, 2018 & 2027 (%)

FIGURE   20 NORTH AMERICA 3D CELL CULTURE MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS, 2019-2027 ($ MILLION)

FIGURE   21 NORTH AMERICA 3D CELL CULTURE MARKET, BY RESEARCH LABORATORIES AND INSTITUTES, 2019-2027 ($ MILLION)

FIGURE   22 NORTH AMERICA 3D CELL CULTURE MARKET, BY HOSPITALS AND DIAGNOSTIC CENTERS, 2019-2027 ($ MILLION)

FIGURE   23 NORTH AMERICA 3D CELL CULTURE MARKET, BY OTHER END USERS, 2019-2027 ($ MILLION)

FIGURE   24 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BY COMPONENT, 2018 & 2027 (%)

FIGURE   25 NORTH AMERICA 3D CELL CULTURE MARKET, BY MEDIA, 2019-2027 ($ MILLION)

FIGURE   26 NORTH AMERICA 3D CELL CULTURE MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)

FIGURE   27 PORTER’S FIVE FORCE MODEL

FIGURE   28 THE UNITED STATES 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)

FIGURE   29 CANADA 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)

 

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY TECHNOLOGY
    • SCAFFOLD BASED
      • HYDROGELS
      • POLYMERIC SCAFFOLDS
      • MICROPATTERNED SURFACE MICROPLATES
    • SCAFFOLD FREE
      • HANGING DROP MICROPLATES
      • SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
      • MICROFLUIDIC 3D CELL CULTURE
      • MAGNETIC LEVITATIONS & 3D BIOPRINTING
    • 3D BIOREACTORS
  2. MARKET BY APPLICATION
    • CANCER
    • TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY
    • DRUG DEVELOPMENT
    • STEM CELL RESEARCH
    • OTHER APPLICATION
  3. MARKET BY END-USER
    • BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS
    • RESEARCH LABORATORIES AND INSTITUTES
    • HOSPITALS AND DIAGNOSTIC CENTERS
    • OTHER END USERS
  4. MARKET BY COMPONENT
    • MEDIA
    • REAGENTS AND CONSUMABLES